deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT04892680

Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes

Enhancing Cardiometabolic Care Study

Sponsor: Omada Health, Inc.

Updated 4 times since 2021 Last updated: May 5, 2022 Started: Mar 4, 2021 Primary completion: Aug 2, 2021 Completion: Aug 2, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated prematurely due to operational futility.

A NA clinical study on Type 2 Diabetes, this trial is terminated or withdrawn. The trial is conducted by Omada Health, Inc. and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2021 – ~Jun 2022 · 12 months · monthly snapshotEnrolling By Invitation~Jun 2022 – ~Jul 2024 · 25 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jun 2022 — Jul 2024 [monthly]

    Terminated NA

    Status: Enrolling By InvitationTerminated

  4. Jun 2021 — Jun 2022 [monthly]

    Enrolling By Invitation NA

    First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Omada Health, Inc.
  • Palo Alto Medical Foundation
  • Sutter Health
Data source: Omada Health, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations